trending Market Intelligence /marketintelligence/en/news-insights/trending/n7ddet9qak3oabxc08wdya2 content esgSubNav
In This List

Carlyle acquires minority stake in Ambio Holdings


Banking Essentials Newsletter: September Edition, Part - 2


S&P Capital IQ Pro | Unrivaled Sector Coverage


S&P Capital IQ Pro | Powering Your Edge


Street Talk Episode 81: Amid strong recovery, Banc of California hearing more M&A chatter

Carlyle acquires minority stake in Ambio Holdings

Carlyle Group LP, a global alternative asset manager, bought a "significant" minority stake in biotechnology company Ambio Holdings Inc. from MVM Partners LLP, a healthcare-focused private equity firm.

Carlyle made the acquisition in Ambio, which produces peptides for drugs approved by U.S., Chinese and European agencies, via its Carlyle Asia Partners V, a $6.55 billion fund for buyout and strategic investments in the Asia-Pacific region.

MVM still holds a significant interest in Ambio Holdings.

The terms of the transaction were not disclosed.

The asset management firm had invested more than $11.5 billion in the global healthcare industry, with an estimated $1.5 billion spent on healthcare companies in Asia as of June 30.